Sudarshan Pharma Industries Ltd vs UltraTech Cement Limited

A side-by-side comparison of Sudarshan Pharma Industries Ltd (SUDARSHAN) and UltraTech Cement Limited (ULTRACEMCO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, UltraTech Cement Limited leads SUDARSHAN vs ULTRACEMCO on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ULTRACEMCO takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.08
P/E ratio
38.36
5.72
P/B ratio
4.25
0.77%
Dividend yield
2.19%
₹0.97
EPS
₹277.62

Profitability

ULTRACEMCO takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.03%
Return on equity
10.66%
12.78%
Return on capital
12.88%
7.30%
EBITDA margin
19.23%
3.32%
Net margin
9.25%

Growth

SUDARSHAN takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

15.11%
Revenue CAGR (3Y)
11.86%
49.46%
Profit CAGR (3Y)
17.30%

Size & financial health

ULTRACEMCO takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹874 Cr
Market cap
₹3.13L Cr
₹703 Cr
Revenue
₹88,512 Cr
₹23 Cr
Net profit
₹8,188 Cr
1.84
Debt / equity
0.30
Sudarshan Pharma Industries Ltd
  • + ["Company has delivered good profit growth of 50.8% CAGR over last 5 years", "Company has delivered good sales growth of 29.5% CAGR over last 5 years"]
  • − ["Stock is trading at 5.63 times its book value", "Company has a high debt to equity ratio of 1.84."]
UltraTech Cement Limited
  • + ["Company has been maintaining a healthy dividend payout of 86.4%"]
  • − []
Sudarshan Pharma Industries Ltd full analysis UltraTech Cement Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.